EphB4-HSA fusion protein
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for EphB4-HSA fusion protein, covering 2025-11-10 to 2025-11-10. Get the full timeline:
Most recent: Clinical Trial Update: Recombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With Advanced or Metastatic Solid Tumors [Phase 1]